Pangaea Oncology, S.A. (BME: PANG)
Health Care · Life Sciences Tools & Services · ES
€1.43
0.00% today · -18.3% 1Y
Pangaea Oncology, S.A. (BME: PANG) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $57.80M and employs 165 people.
Over the last twelve months the share price has lost 18.3%, trading between 1.43 and 1.75.
Tweenvest scores Pangaea Oncology, S.A. across four factors: quality 60/100, value 66/100, growth 71/100. Its strongest factor is growth.
PANG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $57.80M
- Revenue (TTM)
- $17.05M
- P/E
- —
- EPS
- -0.10
- Dividend yield
- —
- Beta (5Y)
- 0.01
- 52-week high
- €1.75
- 52-week low
- €1.43
- Avg volume (3M)
- —
- Shares outstanding
- 35.91M
- Employees
- 165
- Next earnings
- —
About Pangaea Oncology, S.A.
Pangaea Oncology, S.A. delivers essential medical services to cancer patients across Spain and other European Union countries. Its extensive offerings encompass advanced molecular diagnostics, which include mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression profiling. The company is also active in clinical trials and provides in vitro drug profiling, employing techniques like MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing. Furthermore, Pangaea operates a specialized Dx platform for validating companion diagnostic platforms, benchmarking them against commercial alternatives, and offering bespoke research and development services to other diagnostic firms. A key focus also involves biomarker discovery, aiming to pinpoint novel targets for targeted therapies in their pre-clinical stages. Established in 2006, Pangaea Oncology, S.A. is headquartered in Barcelona, Spain.
- ISIN
- ES0105221008
- Founded
- 2006
- Listed since
- Sep 19, 2017
- Exchange
- Bolsas y Mercados Espanoles
- Currency
- EUR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Immuno-Biological Laboratories Co., Ltd.TSE: 4570 | $67.61M | ¥1,145.00 | -5.37% |
| Fabtech Technologies LimitedNSEI: FABTECH | $65.56M | Rs142.01 | -2.62% |
| Influx Healthtech LimitedNSEI: INFLUX | $61.55M | Rs256.00 | -9.04% |
| Circle8 Group, Inc.NasdaqGM: CIRC | $58.40M | $0.45 | -12.63% |
| Carna Biosciences, Inc.TSE: 4572 | $55.80M | ¥413.00 | -9.23% |
| hVIVO plcAIM: HVO | $54.54M | £0.06 | +2.50% |
| Chiome Bioscience Inc.TSE: 4583 | $51.04M | ¥102.00 | -0.97% |
| ENCell Co., Ltd.KOSDAQ: A456070 | $49.14M | ₩6,000.00 | +1.35% |
Figures last refreshed Oct 4, 2026.